The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PT, BTU and BIIB

The MarketWatch News Department was not involved in the creation of this content.

November 23, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 23, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Pintec Technology Holdings Limited (NASDAQ:PT)

This lawsuit is on behalf of shareholders who purchased PT securities pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s October 2018 initial public offering.

A class action has commenced on behalf of certain shareholders in Pintec Technology Holdings Limited. The filed complaint alleges that defendants made materially false and/or misleading

Read More

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biogen, Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”). Biogen investors have until January 12, 2021 to file a lead plaintiff motion.

Investors suffering losses on their Biogen investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected]

Biogen develops therapies for treating neurological and neurodegenerative diseases. One of its product candidates is aducanumab (BIIB037), an investigational human monoclonal antibody studied for use as a treatment for early Alzheimer’s disease.

On October 22, 2019, the Company announced that it would seek regulatory approval from the U.S. Food and Drug Administration (“FDA”) for aducanumab “based

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of HP Inc. (HPQ) Investors

LOS ANGELES, Nov. 24, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired HP Inc. (“HP” or the “Company”) (NYSE: HPQ) common stock between November 6, 2015 and June 21, 2016, inclusive (the “Class Period”). HP investors have until January 4, 2021 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On June 21, 2016, after the market closed, HP revealed that it would reduce its Supplies channel inventory by $450 million, resulting in a corresponding reduction of $450 million in Supplies revenue over the remainder of 2016. 

On this news, HP’s stock price fell $0.72, or 5.4%, to close at $12.61 per share on June 22, 2016.

The complaint filed in this

Read More

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Berry Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Berry Corporation (“Berry” or “the Company”) (NASDAQ: BRY) violations of the federal securities laws.

Investors who purchased the Company’s shares pursuant and/or traceable to the Company’s July 26, 2018 initial public offering (the “IPO”), or between July 26, 2018 and November 3, 2020 both dates inclusive (the “Class Period”), are encouraged to contact the firm before January 21, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case, has not

Read More

Norfolk City Council to hear pro-gun group’s proposal to prohibit local gun law changes

NORFOLK, Va. (WAVY) — Voters have two chances to let their views be known on a proposed ordinance that would prohibit any further changes to local gun laws.

The public hearings were scheduled after a pro-gun group — the Norfolk 2nd Amendment Preservation Coalition — was successful in gathering enough signatures to force City Council to hold them.

The public hearings are scheduled for Tuesday and Dec. 8.

As written, the ordinance states that the city would not exercise any “authority granted to it” to regulate or prohibit the purchase, possession, transfer, ownership, carrying, storage or transporting of firearms, ammunition or components, or any combination of those items.

In addition, the ordinance also calls for the city to waive its sovereign immunity as it relates to any injury sustained by a person in a designated firearm-free zone.

“I don’t want them to regulate guns outside anything they’ve already done in

Read More

ALERT DEC. 22 DEADLINE Pawar Law Group Announces a Securities Class Action Lawsuit Against …

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) from March 10, 2020 through September 8, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Innate Pharma S.A. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email  [email protected]  for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Innate touted the results of their various Phase 2 trials as being within expectations; (2) Innate continued to reassure investors that they were eligible for the $100 million payment upon first dosing of Phase 3 trials; (3) Innate failed to timely disclose their renegotiations with

Read More

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Berry Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Berry Corporation (“Berry” or “the Company”) (NASDAQ: BRY) violations of the federal securities laws.

Investors who purchased the Company’s shares pursuant and/or traceable to the Company’s July 26, 2018 initial public offering (the “IPO”), or between July 26, 2018 and November 3, 2020 both dates inclusive (the “Class Period”), are encouraged to contact the firm before January 21, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case, has not

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of JOYY Inc. (YY) Investors

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired JOYY Inc. (“JOYY” or the “Company”) (NASDAQ: YY) securities between April 28, 2016 and November 18, 2020, inclusive (the “Class Period”). JOYY investors have until January 19, 2021 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On November 18, 2020, Muddy Waters Research published a report entitled “YY: You Can’t Make This Stuff Up. Well…Actually You Can,” alleging that the Company “is a multibillion-dollar fraud.” The report concluded “that YY’s component businesses are a fraction of the size it reports, and that the company’s reported user metrics, revenues, and cash balances are predominantly fraudulent[,]” and that “[a]pproximately 84% of YY’s reported consolidated revenue appears to be fraudulent.”

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Biogen, Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”). Biogen investors have until January 12, 2021 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On October 22, 2019, the Company announced that it would seek regulatory approval from the U.S. Food and Drug Administration (“FDA”) for aducanumab “based on a new analysis, conducted by Biogen in consultation with the FDA, of a larger dataset from the Phase 3 clinical studies that were discontinued in March 2019 following a futility analysis.” According to Biogen, the new analysis “show[ed] that aducanumab is pharmacologically and clinically active as

Read More

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against K12 Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against K12 Inc. (“K12” or “the Company”) (NYSE: LRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between April 27, 2020 and September 18, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before January 19, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case,

Read More